Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07869693Not yet recruiting
Randomised, double-blind trial of norepinephrine in sepsis and hypotension (2 arms), sponsored by Assiut University. Primary endpoint: Incidence of post-induction hypotension. Planned start Oct 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07869693.